Early research (Phase 1)Study completedNCT05373485What this trial is testingPhase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and OlderWho this might be right forCOVID-19 CanSino Biologics Inc. 43
Not applicableStudy completedNCT04918888What this trial is testingCOVID-19 Vaccination in Oncologic PatientsWho this might be right forCovid19Oncologic Disorders Krankenhaus Barmherzige Schwestern Linz 1,150
Large-scale testing (Phase 3)UnknownNCT05323461What this trial is testingEvaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster VaccinesWho this might be right forCOVID-19SARS-CoV-2 Infection Sinocelltech Ltd. 1,800
Testing effectiveness (Phase 2)Study completedNCT06821061What this trial is testingLearn About How the Flu and COVID-19 Vaccines Act in Healthy PeopleWho this might be right forInfluenzaCOVID-19 (Coronavirus Disease 2019) BioNTech SE 2,650
Not applicableStudy completedNCT04731870What this trial is testingExploring Vaccine Confidence and Uptake of Potential COVID-19 VaccinesWho this might be right forCoronavirus East Carolina University 632
Post-approval studies (Phase 4)Study completedNCT04894227What this trial is testingLot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy AdultsWho this might be right forCOVID-19 Sinovac Research and Development Co., Ltd. 1,080
Large-scale testing (Phase 3)Study completedNCT05364242What this trial is testingVLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 InfectionWho this might be right forSARS-CoV-2 Infection Valneva Austria GmbH 178
Early research (Phase 1)Study completedNCT05385991What this trial is testingBooster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.Who this might be right forSARS-CoV-2 Infection ACM Biolabs 38
Testing effectiveness (Phase 2)Study completedNCT05210179What this trial is testingPhase 2b Booster Vaccination (TURKOVAC) Against COVID-19Who this might be right forCOVID-19Sars-CoV-2 Infection Health Institutes of Turkey 65
Not applicableUnknownNCT05492643What this trial is testingThe Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 VaccineWho this might be right forSARS-CoV-2SafetyImmunotoxicity Zhongnan Hospital 1,000
Not applicableStudy completedNCT05328479What this trial is testingPlasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in ThailandWho this might be right forCOVID-19 Mahidol University 5,181
Large-scale testing (Phase 3)UnknownNCT05096845What this trial is testingRecombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase IIIWho this might be right forCOVID-19 Pandemic Livzon Pharmaceutical Group Inc. 22,500
Post-approval studies (Phase 4)Study completedNCT05107557What this trial is testingImmunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)Who this might be right forCOVID-19 Sinovac Biotech Co., Ltd 520
Post-approval studies (Phase 4)Ended earlyNCT05543642What this trial is testingThe COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)Who this might be right forRheumatic Diseases Oregon Health and Science University 129
Testing effectiveness (Phase 2)WithdrawnNCT05239975What this trial is testingThe Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 VaccineWho this might be right forCOVID-19SARS-CoV2 Infection Sinocelltech Ltd.
Testing effectiveness (Phase 2)Study completedNCT04527081What this trial is testingStudy of COVID-19 DNA Vaccine (AG0302-COVID19)Who this might be right forCOVID-19 AnGes, Inc. 30
Large-scale testing (Phase 3)Study completedNCT04368728What this trial is testingStudy to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy IndividualsWho this might be right forSARS-CoV-2 InfectionCOVID-19 BioNTech SE 46,969
Not applicableStudy completedNCT05270967What this trial is testingFDG (Fluorodeoxyglucose) Findings After COVID-19 VaccinationWho this might be right forVaccine ReactionOncology Kocaeli University 129
Large-scale testing (Phase 3)Study completedNCT05265065What this trial is testingEvaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.Who this might be right forCOVID-19 Murdoch Childrens Research Institute 601
Large-scale testing (Phase 3)Study completedNCT04754594What this trial is testingTo Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and OlderWho this might be right forSARS-CoV-2 InfectionCOVID-19Maternal Immunization BioNTech SE 726